Pre-treatment DNA methylome and transcriptome profiles correlate with melanoma response to anti-PD1 immunotherapy
Cancer Letters · 2025
DOI: 10.1016/j.canlet.2025.217638 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Sultana Mehbuba Hossain und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery, Le…. Hauptthemen laut MEDLINE: Melanoma, DNA Methylation, Immune Checkpoint Inhibitors, Transcriptome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Council of New Zealand, Royal Society of New Zealand, University of Otago.
Abstract (Originalsprache)
Successful immune checkpoint inhibitor (ICI) therapy occurs in only a fraction of melanoma patients, and yet all patients are susceptible to potentially serious ICI-related side-effects. No current biomarkers robustly predict ICI treatment response in melanoma patients. In this study we sought to identify methylome and transcriptome markers which have the potential to predict immunotherapy response in melanoma patients ahead of treatment with anti-PD1 ICI monotherapy. Using Infinium MethylationEPIC microarrays, we analysed DNA methylation profiles of >850,000 CpG sites in pre-treatment melanoma tissues from patients administered anti-PD-1 monotherapy as first-line treatment. In addition, we analysed transcriptomes using RNA-seq. DNA methylation and gene expression data were then statistically compared to patient response to anti-PD1 therapy. We identified 2579 DNA hypomethylation and hypermethylation alterations correlating with melanoma response to anti-PD1 therapy. An integrative analysis of DNA methylomes and transcriptomes identified a subset of 35 loci, 13 of which were significantly differentially methylated in both initial discovery and external validation datasets. Functional enrichment analysis of hypomethylated sites (p-value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery, Level 2, 3A Symonds Street, Auckland, New Zealand.
- Department of Surgical Sciences, University of Otago, Dunedin, New Zealand.
- Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery, Level 2, 3A Symonds Street, Auckland, New Zealand; Department of Patholo…
- Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
- Department of Tumor Pathology, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch, Krakow, Poland.
- Department of Clinical Oncology, Lower Silesian Oncology Center, Pulmonology and Hematology, Wroclaw, Poland; Department of Hematology and Oncology, Faculty of Medicine, Wroclaw University of Science and Technology, Pol…
Förderung
- Health Research Council of New Zealand
- Royal Society of New Zealand
- University of Otago
- Maurice Wilkins Centre for Molecular Biodiscovery
- Otago Medical Research Foundation
Zitieren
APA
Hossain, S. M., Gimenez, G., Stockwell, P., Weeks, R., Almomani, S., Jones, G. T., Ratajska, M., Shuen, M., Bhat, B., Ryś, J., Cybulska-Stopa, B., Harazin-Lechowska, A., Rodger, E., Jackson, C., Chatterjee, A., & Eccles, M. R. (2025). Pre-treatment DNA methylome and transcriptome profiles correlate with melanoma response to anti-PD1 immunotherapy. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.217638
Vancouver
Hossain SM, Gimenez G, Stockwell P, Weeks R, Almomani S, Jones GT, et al. Pre-treatment DNA methylome and transcriptome profiles correlate with melanoma response to anti-PD1 immunotherapy. Cancer Letters. 2025. doi:10.1016/j.canlet.2025.217638
BibTeX
@article{Hossain2025,
author = {Hossain, Sultana Mehbuba and Gimenez, Gregory and Stockwell, Peter and Weeks, Robert and Almomani, Suzan and Jones, Gregory T and Ratajska, Magdalena and Shuen, Mathew and Bhat, Basharat and Ryś, Janusz and Cybulska-Stopa, Bozena and Harazin-Lechowska, Agnieszka and Rodger, Euan and Jackson, Christopher and Chatterjee, Aniruddha and Eccles, Michael R},
title = {Pre-treatment DNA methylome and transcriptome profiles correlate with melanoma response to anti-PD1 immunotherapy},
journal = {Cancer Letters},
year = {2025},
doi = {10.1016/j.canlet.2025.217638}
}
EUVIMED